Welcome to chemicalbook!
400-158-6606
Try our best to find the right business for you.
Do not miss inquiry messages Please log in to view all inquiry messages.

Welcome back!

tert-Butyl(3-formylbicyclo[1.1.1]pentan-1-yl)carbamate

tert-Butyl(3-formylbicyclo[1.1.1]pentan-1-yl)carbamate Structure
  • ₹0
  • Product name: tert-Butyl(3-formylbicyclo[1.1.1]pentan-1-yl)carbamate
  • CAS: 1638771-06-8
  • MF: C11H17NO3
  • MW: 211.26
  • EINECS:
  • MDL Number:MFCD27987008
  • Synonyms:tert-Butyl(3-formylbicyclo[1.1.1]pentan-1-yl)carbamate;tert-butyl N-{3-formylbicyclo[1.1.1]pentan-1-yl}carbamate;Tert-Butyl (3-Formylbicyclo[1.1.1]Pentan-1-Yl)Carbamate(WX120659);3-(BOC-AMINO)-BICYCLO[1.1.1]PENTANE-1-CARBALDEHYDE;182899;Carbamic acid, N-(3-formylbicyclo[1.1.1]pent-1-yl)-, 1,1-dimethylethyl ester;N-(3-Formylbicyclo[1.1.1]pent-1-yl)-1,1-Dimethylethyl Ester Carbamic Acid;(3-Formyl-bicyclo[1.1.1]pent-1-yl)-carbamic acid tert-butyl ester
Manufacturer Product number Product description Packaging Price Updated Buy

Properties

Boiling point :307.8±41.0 °C(Predicted)
Density :1.15±0.1 g/cm3(Predicted)
pka :12.17±0.40(Predicted)

Safety Information

Symbol(GHS): GHS hazard pictograms
Signal word: Warning
Hazard statements:
Code Hazard statements Hazard class Category Signal word Pictogram P-Codes
H315 Causes skin irritation Skin corrosion/irritation Category 2 Warning GHS hazard pictograms P264, P280, P302+P352, P321,P332+P313, P362
H319 Causes serious eye irritation Serious eye damage/eye irritation Category 2A Warning GHS hazard pictograms P264, P280, P305+P351+P338,P337+P313P
H335 May cause respiratory irritation Specific target organ toxicity, single exposure;Respiratory tract irritation Category 3 Warning GHS hazard pictograms
Precautionary statements:
P261 Avoid breathing dust/fume/gas/mist/vapours/spray.
P305+P351+P338 IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continuerinsing.

Description

Used in the preparation of bicyclic compounds that are useful as EP4 receptor antagonists in the treatment of cancer

Related product price